3TD-14192-19183
2 vaccinations
1 coded response
5 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 477 / IN
- Registered
- 2021-06-25
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-06-25
Registered in v-safe
-
2021-06-25
Dose 1 — Pfizer-BioNTech
-
2021-07-16
Dose 2 — Pfizer-BioNTech
-
2021-07-19
Survey response — days 1–6 daily, dose 2MedDRA: No adverse event — Feeling: GoodFree text: I had no symptoms with first or second vaccine.MedDRA releases: 2024-11 · check-in free text available
- 2021-07-20
- 2021-07-21
- 2021-07-23
- 2021-08-01
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-06-25 | Pfizer-BioNTech | No |
| 2 | 2021-07-16 | Pfizer-BioNTech | No |
Free text
Release 9 — days 1–6 daily, dose 2
Systemic reaction (other): I had no symptoms with first or second vaccine.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | No adverse event | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release